ABOUT US

QOL Medical, LLC is a patient-centric company with a focus on the acquisition and commercialization of orphan drug therapies in underserved markets. QOL Medical’s goal is to expand clinical awareness and patient access to help make a difference in people's lives in the treatment of orphan diseases. QOL Medical currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (ethanolamine oleate) Injection 5%.